Mechanistic insights from animal models of psoriasis and psoriatic arthritis

Current Rheumatology Reports

Volumn 15, Issue 11, 2013, Pages

  Weitz, Joshua E ^a   Ritchlin, Christopher T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Animal models; Dactylitis; Enthesitis; Geneticmutations; IL 17; IL 22; IL 23; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Spondyloarthritis

Indexed keywords

ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DISEASE MODEL; GENETICS; MOUSE; MUTATION; PSORIASIS; SPONDYLARTHRITIS; EXPERIMENTAL ARTHRITIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; MICE; MUTATION; PSORIASIS; SPONDYLARTHRITIS;

EID: 84893778801     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-013-0377-4     Document Type: Article

References (39)

1. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. 2009;60(2):218-24
2. Ritchlin CT, Proulx S, Schwarz ES. Translational perspectives on psoriatic arthritis. J Rheumatol Suppl. 2009;83:30-4
3. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61(10): 1373-8
4. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55-78
5. Blumberg BS et al. Ara nomenclature and classification of arthritis and rheumatism (tentative). Arthritis Rheum. 1964;7:93-7
6. Bluett J, Barton A. What have genome-wide studies told us about psoriatic arthritis? Curr Rheumatol Rep. 2012;14(4):364-8
7. Karason A, Love TJ, Gudbjornsson B. A strong heritability of psoriatic arthritis over four generations-the Reykjavik Psoriatic Arthritis Study. Rheumatology (Oxford). 2009;48(11):1424-8
8. Conrad C, Nestle FO. Animal models of psoriasis and psoriatic arthritis: an update. Curr Rheumatol Rep. 2006;8(5):342-7 (Pubitemid 44638826)
9. Courtenay JS et al. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980;283(5748):666-8 (Pubitemid 10099994)
10. Keffer J et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991;10(13): 4025-31 (Pubitemid 21905432)
11. Hammer RE et al. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease. JInvestig Med. 1995;43(3):262-8
12. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med. 1995;182(4):1153-8
13. Huffmeier U et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet. 2010;42(11):996-9. This genome-wide study revealed an association of Ps and PsA with TRAF3IP2. This may prompt further investigation to find biomarkers that enable prognostication in patients with Ps who may be at risk of PsA
14. Ruutu M et al. beta-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum. 2012;64(7):2211-3 22. This study effectively revealed that the microbial environment towhich animals and possibly humans are exposed can have dramatic effect on inflammation and development of a disease phenotype- notably SpA
15. Wang C et al. The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90. Nat Immunol. 2013;14(1):72-81. This study revealed that a loss of function mutation in Act1 and chaperone protein hsp90, which results in absence of IL-17, was still associated with the development of inflammatory skin lesions that were driven by IL-22, implicating this cytokine as a potential therapeutic target
16. Yoshitomi H et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med. 2005;201(6):949-60 (Pubitemid 40524464)
17. Adamopoulos IE et al. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol. 2011;187(2):951-9. Introduction of minicircle DNA, a novel technique, for study of spondyloarthritis in animals. Affirms the role of IL-23 in the initiation and perpetuation of disease
18. Sakaguchi N et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature.2003;426(6965):454- 60 (Pubitemid 37490133)
19. Cook PWet al. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasislikeskin pathology: expression of amphiregulin in the basal epidermisis also associated with synovitis. Exp Dermatol. 2004;13(6):347-56 (Pubitemid 38868207)
20. Genetic Analysis of Psoriasis, C et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42(11):985-90
21. Ritchlin CT, FitzGerald O. Psoriatic and reactive arthritis: a companion to rheumatology. 1st ed. Philadelphia:Mosby Elsevier; 2007. p. 16. 236 p
22. Nunn CL, Rothschild B, Gittleman JL. Why are some species more commonly afflicted by arthritis than others? A comparative study of spondyloarthropathy in primates and carnivores. J Evol Biol.2007;20(2):460-70
23. Wagner EF et al. Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol. 2010;6(12):704-14
24. Anandarajah A. Imaging in psoriatic arthritis. Clin Rev Allergy Immunol. 2013;44(2):157-65
25. Ory PA,Gladman DD,Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis. 2005;64 Suppl 2:ii55-7 (Pubitemid 40288523)
26. Kollias G et al. Animal models for arthritis: innovative tools for prevention and treatment. Ann Rheum Dis. 2011;70(8):1357-62
27. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol. 2003;25(1):3-18 (Pubitemid 37000035)
28. Li P, Schwarz EM. The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol. 2003;25(1):19-33 (Pubitemid 37000036)
29. Zenz R et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature. 2005;437(7057):369-75 (Pubitemid 41613493)
30. Nair RP et al.Genome-wide scan reveals association of psoriasis with IL-23 and NF- kappaB pathways. Nat Genet. 2009;41(2):199-204
31. Colbert RA et al. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev. 2010;233(1):181-202
32. Sherlock JP et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. NatMed. 2012;18(7):1069-76. This study also used the minicircle DNA technique and effectively revealed IL-23-induced inflammation is related to bone erosion whereas IL-22 ma have a role in new bone formation
33. Lories RJ,McInnes IB. Primed for inflammation: enthesis-resident T cells. Nat Med. 2012;18(7):1018-9
34. Ellinghaus E et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet. 2010;42(11):991-5
35. Bardos T et al. Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age. Arthritis Rheum. 2002;46(9):2465-75
36. Lories RJ et al. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis. 2004;63(5):595-8 (Pubitemid 38530208)
37. Braem K et al. Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis. Arthritis Res Ther. 2012;14(2):R59. Model that provides an explanation for the uncoupling of bone homeostasis seen in spondyloarthritides as evidenced by the inability of glucocorticoids to prevent new bone formation after abrogating inflammatory response. Lends redence to the "entheseal stress " hypothesis
38. Braem K, Carter S, Lories RJ. Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in " stress-induced arthritis ". Biol Proced Online. 2012;14(1):10
39. McInnes IB, et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet. 2013